Table 2.
Heterogeneity test and horizontal pleiotropy test.
| Exposure | Outcome | Heterogeneity test | Horizontal pleiotropy test | ||||
|---|---|---|---|---|---|---|---|
| Method | Cochran’s Q | Q_ pval | Egger_intercept | Se | pval | ||
| Hyperthyroidism (Handan et al.) | Esophageal cancer (UKB) | MR Egger | 35.99 | 0.799 | <0.001 | <0.001 | 0.457 |
| IVW | 36.55 | 0.811 | |||||
| Esophageal cancer (UKB) | Hyperthyroidism (Handan et al.) | MR Egger | 21.75 | 0.649 | -0.001 | 0.001 | 0.324 |
| IVW | 22.76 | 0.646 | |||||
| Hyperthyroidism (UKB) | GERD (Handan et al.) |
MR Egger | 39.95 | 0.341 | 0.001 | 0.001 | 0.472 |
| IVW | 40.52 | 0.359 | |||||
| GERD (Handan et al.) |
Hyperthyroidism (UKB) | MR Egger | 39.95 | 0.341 | 0.001 | 0.001 | 0.619 |
| IVW | 40.52 | 0.359 | |||||
IVW, inverse-variance weighted; GERD, gastroesophageal reflux; UKB, UK Biobank; MR, Mendelian randomization. Statistical significance: p < 0.05.